Skip to content
Versanis
Science
Our Approach
Areas of Focus
Obesity
Heart Failure in Obesity
Pipeline
Scientific Publications
About Us
Our Focus
Leadership Team
Board of Directors
News
Careers
Contact
Long-term safety and tolerability of bimagrumab (BYM338) in sporadic inclusion body myositis
